FDA MedWatch - TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules

If your email program has trouble displaying this email, view it as a web page

MedWatch - The FDA Safety Information and Adverse Event Reporting Program A new MedWatch Safety Alert:TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules intended for: Patient, Pharmacy, Health Professional was just added to the FDA MedWatch Webpage.   You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm609064.htm

U.S. Food and Drug Administration 10903 New Hampshire Avenue, Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Privacy Policy | www.fda.gov Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists